Navamedic ASA (NAVA) - Financial and Strategic SWOT Analysis Review

Navamedic ASA (NAVA) - Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH82351FSA
  • |
  • Pages: 47
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Navamedic ASA (NAVA)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Navamedic ASA (Navamedic) is a medtech and pharmaceutical products company, which develops, distributes and markets medicines and medical equipment. Its product portfolio includes branded, generic and patented pharmaceuticals, medical devices, food supplements and other healthcare products. The company offers its products to patients, hospitals and pharmacies in the Nordic, Benelux and Baltic markets. Navamedic offers its pharmaceutical products under mouth and throat health, dermatology, urology, gynecology, cardiology and other categories; and medical devices under urine measurement and psychiatry categories. The company also distributes products supplied by several pharmaceutical manufacturers. Navamedic is headquartered in Lysaker, Norway.

Navamedic ASA Key Recent Developments

May 30,2018: Navamedic Announces Q1 2018 results

Feb 15,2018: Navamedic: Q4 2017 Results

Nov 10,2017: Navamedic: Q3 2017 results

Jul 28,2017: Navamedic ASA: Second quarter results 2017

Jul 28,2017: Navamedic: Second quarter results 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Navamedic ASA-Key Facts 6

Navamedic ASA-Key Employees 7

Navamedic ASA-Key Employee Biographies 8

Navamedic ASA-Key Operational Employees 9

Navamedic ASA-Major Products and Services 10

Navamedic ASA-History 11

Navamedic ASA-Company Statement 15

Navamedic ASA-Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Section 2-Company Analysis 17

Company Overview 17

Navamedic ASA-Business Description 18

Business Segment: Medtech 18

Overview 18

Performance 18

Business Segment: Pharma and Healthcare 18

Overview 18

Performance 18

Geographical Segment: Denmark 18

Performance 18

Geographical Segment: Finland 19

Performance 19

Geographical Segment: Norway 19

Performance 19

Geographical Segment: Other countries 19

Performance 19

Geographical Segment: Sweden 19

Performance 19

Navamedic ASA-Corporate Strategy 20

Navamedic ASA-SWOT Analysis 21

SWOT Analysis-Overview 21

Navamedic ASA-Strengths 21

Navamedic ASA-Weaknesses 22

Navamedic ASA-Opportunities 23

Navamedic ASA-Threats 24

Navamedic ASA-Key Competitors 25

Section 3-Company Financial Ratios 26

Financial Ratios-Capital Market Ratios 26

Financial Ratios-Annual Ratios 27

Performance Chart 30

Financial Performance 30

Financial Ratios-Interim Ratios 31

Financial Ratios-Ratio Charts 32

Section 4-Company's Lifesciences Financial Deals and Alliances 33

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 33

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 34

Navamedic ASA, Recent Deals Summary 35

Section 5-Company's Recent Developments 36

May 30, 2018: Navamedic Announces Q1 2018 results 36

Feb 15, 2018: Navamedic: Q4 2017 Results 37

Nov 10, 2017: Navamedic: Q3 2017 results 38

Jul 28, 2017: Navamedic ASA: Second quarter results 2017 39

Jul 28, 2017: Navamedic: Second quarter results 2017 40

May 10, 2017: Navamedic: Q1 2017 Results 41

Feb 15, 2017: Navamedic: Q4 2016 results 42

Section 6-Appendix 43

Methodology 43

Ratio Definitions 43

About GlobalData 47

Contact Us 47

Disclaimer 47

List of Figures

Navamedic ASA, Performance Chart (2013-2017) 30

Navamedic ASA, Ratio Charts 32

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 33

Navamedic ASA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 34

List of Tables

Navamedic ASA, Key Facts 6

Navamedic ASA, Key Employees 7

Navamedic ASA, Key Employee Biographies 8

Navamedic ASA, Key Operational Employees 9

Navamedic ASA, Major Products and Services 10

Navamedic ASA, History 11

Navamedic ASA, Subsidiaries 16

Navamedic ASA, Key Competitors 25

Navamedic ASA, Ratios based on current share price 26

Navamedic ASA, Annual Ratios 27

Navamedic ASA, Annual Ratios (Cont...1) 28

Navamedic ASA, Annual Ratios (Cont...2) 29

Navamedic ASA, Interim Ratios 31

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 33

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 34

Navamedic ASA, Recent Deals Summary 35

Currency Codes 43

Capital Market Ratios 43

Equity Ratios 44

Profitability Ratios 44

Cost Ratios 45

Liquidity Ratios 45

Leverage Ratios 46

Efficiency Ratios 46

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Weifa ASA

Vingmed AS

Photocure ASA

Laerdal Medical AS

Immunocorp Consumer Health

Bluefish Pharma Incentive AB

Navamedic ASA, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8920
Site License
USD 250 INR 17840
Corporate User License
USD 375 INR 26760

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com